Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
Immunai

Immunai

Comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes

Last updated on

About Immunai

Founded

2019

Estimated Revenue

$10M-$50M

Employees

51-250

Funding / Mkt. Cap

$295M

Category

Sector

Information Technology

Industry Group

Software & Services

Industry

Software

SIC Code

73

NAICs Code

51

Location

City

New York

State

New York

Country

United States
Immunai

Immunai

Find your buyer within Immunai

Tech Stack (68)

search